4C Medical Technologies
Mr. Handegard joined 4C Medical as Chief Financial Officer in June 2022. He has extensive experience working with both venture capitol and individual investors on the investment side; mostly recently contributing to the successful sale of a technology company and arranging additional equity for a Twin Cities software company. In addition, Mr. Handegard has 30+ years of experience in accounting, financial management, financial reporting and administration for small technology companies.
This person is not in any teams
This person is not in any offices
4C Medical Technologies
4C Medical Technologies is a medical device company that develops minimally invasive therapies for structural heart disease.